Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000518634 | SCV000616223 | uncertain significance | not specified | 2017-03-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001724037 | SCV003462664 | uncertain significance | not provided | 2022-05-04 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. ClinVar contains an entry for this variant (Variation ID: 448845). This variant has not been reported in the literature in individuals affected with TUBB2B-related conditions. This variant is present in population databases (rs767477213, gnomAD 0.006%). This sequence change falls in intron 1 of the TUBB2B gene. It does not directly change the encoded amino acid sequence of the TUBB2B protein. It affects a nucleotide within the consensus splice site. |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001724037 | SCV001956957 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001724037 | SCV001965965 | likely benign | not provided | no assertion criteria provided | clinical testing |